Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyoung-Ho Pyo

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 13, 2016
Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung CancerKyoung Ho Pyo, Sun Min Lim, Hye Ryun Kim, et al.
Yonsei Medical Journal|August 28, 2024
Exploring the Expression and Function of T Cell Surface Markers Identified through Cellular Indexing of Transcriptomes and Epitopes by SequencingJoon Yeon Hwang, Youngtaek Kim, Kwangmin Na, et al.
Scientific Reports|December 29, 2019
Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung AdenocarcinomaSeok-Young Kim, Ji Yeon Lee, Dong Hwi Kim, et al.
Molecular Cancer Therapeutics|July 26, 2015
Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung AdenocarcinomaChan Woo Kang, Kang Won Jang, Jinyoung Sohn, et al.
Yonsei Medical Journal|November 28, 2024
Mutation-Driven Immune Microenvironments in Non-Small Cell Lung Cancer: Unrevealing Patterns through Cluster AnalysisYoungtaek Kim, Joon Yeon Hwang, Kwangmin Na, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer modelsHan Na Kang, Se-Ho Kim, Mi Ran Yun, et al.
Journal for Immunotherapy of Cancer|July 31, 2020
Comprehensive analyses of immunodynamics and immunoreactivity in response to treatment in <i>ALK</i>-positive non-small-cell lung cancerKyoung-Ho Pyo, Sun Min Lim, Chae-Won Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung CancerJiyeon Yun, Min Hee Hong, Seok-Young Kim, et al.
Cancers|September 28, 2023
Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic StrategiesYoungtaek Kim, Joon Yeon Hwang, Dong Kwon Kim, et al.
Yonsei Medical Journal|December 16, 2021
Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin TumorChun-Bong Synn, Dong Kwon Kim, Jae Hwan Kim, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 13, 2016
Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung CancerKyoung Ho Pyo, Sun Min Lim, Hye Ryun Kim, et al.
Yonsei Medical Journal|August 28, 2024
Exploring the Expression and Function of T Cell Surface Markers Identified through Cellular Indexing of Transcriptomes and Epitopes by SequencingJoon Yeon Hwang, Youngtaek Kim, Kwangmin Na, et al.
Scientific Reports|December 29, 2019
Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung AdenocarcinomaSeok-Young Kim, Ji Yeon Lee, Dong Hwi Kim, et al.
Molecular Cancer Therapeutics|July 26, 2015
Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung AdenocarcinomaChan Woo Kang, Kang Won Jang, Jinyoung Sohn, et al.
Yonsei Medical Journal|November 28, 2024
Mutation-Driven Immune Microenvironments in Non-Small Cell Lung Cancer: Unrevealing Patterns through Cluster AnalysisYoungtaek Kim, Joon Yeon Hwang, Kwangmin Na, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer modelsHan Na Kang, Se-Ho Kim, Mi Ran Yun, et al.
Journal for Immunotherapy of Cancer|July 31, 2020
Comprehensive analyses of immunodynamics and immunoreactivity in response to treatment in <i>ALK</i>-positive non-small-cell lung cancerKyoung-Ho Pyo, Sun Min Lim, Chae-Won Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung CancerJiyeon Yun, Min Hee Hong, Seok-Young Kim, et al.
Cancers|September 28, 2023
Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic StrategiesYoungtaek Kim, Joon Yeon Hwang, Dong Kwon Kim, et al.
Yonsei Medical Journal|December 16, 2021
Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin TumorChun-Bong Synn, Dong Kwon Kim, Jae Hwan Kim, et al.
Pageof 6